Chris Ryerson
Associate ProfessorAbout
Dr. Chris Ryerson completed his core clinical training at the University of British Columbia and an interstitial lung disease (ILD) fellowship and Masters degree in clinical research at the University of California San Francisco before joining UBC faculty in 2011. He is an Associate Professor at UBC, director of the St. Paul’s Hospital ILD clinical and research program, and Head of the Division of Respiratory Medicine at Providence Health Care. His research focuses on the diagnosis, management, and prognostication of ILD. He is also involved in several national and international clinical practice guidelines on the diagnosis and management of fibrotic ILD.
Education & Training
- BScH, Life Sciences, Queen’s University (1996-2000)
- MD, University of Western Ontario (2000-2004)
- Resident, Internal Medicine, University of British Columbia (2004-2007)
- Fellow, Respiratory Medicine, University of British Columbia (2007-2009)
- Fellow, Clinical Investigator Program, University of British Columbia (2009-2011)
- Fellow, Interstitial Lung Disease, University of California San Francisco (2009-2011)
- MAS, Masters in Clinical Research, University of California San Francisco (2009-2011)
Area of Interest
Dr. Ryerson’s research focuses on the diagnosis, management, and prognostication of pulmonary fibrosis. This includes recent work on frailty and body composition as well as several studies exploring the benefits of oxygen supplementation in patients with pulmonary fibrosis and optimal strategies for its use. Dr. Ryerson leads the Canadian Registry for Pulmonary Fibrosis (CARE-PF), an 8-centre prospective registry that is among the largest in the world, as well as the HOPE-IPF study, which is a randomized controlled trial evaluating the clinical and physiological impact of oxygen supplementation during exercise training in patients with idiopathic pulmonary fibrosis. Dr. Ryerson has also been involved in several national and international clinical practice guidelines on the diagnosis and management of pulmonary fibrosis.
Team Members
- Ferhan Saleem, PhD candidate
- Alyson Wong, post-doctoral fellow
- Sana Vahidy, post-doctoral fellow
- Daniel Marinescu, post-doctoral fellow
- Tao Chen, visiting student